Search
for
Sort by
Research 31–60 of 48
- Polycystic Ovarian Disease: Current Insights and therapeutic Strategies
- Chemically Induced Hair Loss/Alopecia
- Cytostatics and immunosuppressive drugs
- Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7
- Disorders of excessive hair growth in the adolescent
- 9 Diagnosis and therapy of hyperandrogenism
- Hirsutism
- Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
- Estrus, ovulation, and serum progesterone, estradiol, and LH concentrations in mares after an increased photoperiod during winter.
- Diseases associated with hidranitis suppurativa: part 2 of a series on hidradenitis
- Hypogonadism as a Reversible Cause of Torsades de Pointes in Men
- Follicular Fluid: A Powerful Tool for the Understanding and Diagnosis of Polycystic Ovary Syndrome
- Invasion and increased expression of S100A4 and CYR61 in mesenchymal transformed breast cancer cells is downregulated by GnRH
- Menopausal Androgen Excess - Associated Cardio-Metabolic Risk: Clues for Ovarian Leydig Cell Tumour (Case Report and Mini-Review of Literature)
- Impacts of Anabolic-androgenic steroid supplementation on female health and offspring: Mechanisms, side effects, and medical perspectives
- Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone
- Rationale and design of the GLADE study: a randomized, multicenter, double-blind, placebo-controlled trial evaluating the safety and efficacy of gestrinone subdermal bioabsorbable pellet in endometriosis-related pelvic pain
- POLİKİSTİK OVER SENDROMU'NUN ALT GRUPLARINDA METABOLİK ÖZELLİKLER
- The effect of treatment with an LH-RH agonist (Buserelin) on gonadal activity growth and bone maturation in children with central precocious puberty
- Efficacy of low-dose GnRH analogue (Buserelin) in the treatment of hirsutism
- Hormonal Treatments in Hidradenitis Suppurativa: A Systematic Review
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
- Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)
- Health Care-Related Economic Burden of the Polycystic Ovary Syndrome during the Reproductive Life Span
- Is dehydroepiandrosterone a hormone?
- Hormonal Therapy for Acne
- Hormonal therapy for acne: why not as first line therapy? facts and controversies
- Dermatologic Manifestations of Polycystic Ovary Syndrome
- The dihydrotestosterone (DHT) hypothesis of prostate cancer and its therapeutic implications